Prof Tan Say Beng

Prof Tan Say Beng

  • Executive Director

    National Medical Research Council Ministry of Health

  • Group Chief Research Officer

    Singapore Health Services Pte Ltd

  • Senior Associate Dean

    Duke-NUS Medical School

Tan Say Beng is Group Chief Research Officer, Singapore Health Services (SingHealth) and Senior Associate Dean, Research, Duke-NUS Medical School. He is concurrently also Executive Director of the National Medical Research Council (NMRC) and holds or has held faculty appointments with the National University of Singapore’s (NUS) Yong Loo Lin School of Medicine and Saw Swee Hock School of Public Health, as well as the Department of Biostatistics and Bioinformatics at Duke University. He serves on various Boards and Oversight Committees, including the Singapore Clinical Research Institute, the National Health Innovation Centre, the Advanced Cell Therapy and Research Institute and the Singapore Sports Institute Science Technology and Innovation Advisory Board.

As Group Chief Research Officer SingHealth, Say Beng provides broad oversight of research initiatives and infrastructure in the SingHealth healthcare cluster. This includes research ethics and regulatory compliance, talent development, research operations and research support platforms. He also drives strategic planning and research policy development, champions research collaborations and engages with national and international research funders and stakeholders. In his complementary role as Senior Associate Dean, Research, at Duke-NUS, he supports the work of the Office of Research to ensure close research partnerships between Duke-NUS and SingHealth.

As Executive Director of NMRC, he supports the development and administration of strategic plans, research policies and funding initiatives to drive biomedical research in Singapore. This included leading NMRC to come up with the first ever National Healthcare Research Strategy in 2014, to support the National Research Innovation and Enterprise (RIE) Initiatives.

Say Beng’s previous appointments include Senior Vice President and Chief Scientific Officer of SCRI, Head of Strategic Planning and Principal Biostatistician of the National Cancer Centre Singapore, Visiting Consultant to the Health Sciences Authority and Director of the Clinical Trials and Epidemiology Research Unit (CTERU), Singapore.

Say Beng received his initial training in Mathematics at Balliol College, University of Oxford, before proceeding to do a Masters in Applied Statistics there. He then pursued a PhD at Imperial College London in Biostatistics, where he developed Bayesian decision theoretic approaches for the design of clinical trials.

He has more than 70 scientific publications, including first author research articles in leading clinical journals like the BMJ and top research methodology journals like Statistics in Medicine. He has 2 patents to his name, more than 15 research grants as Principal Investigator or Co-Investigator and more than 40 conference abstracts. He has co-authored three books published by Wiley covering the areas of sample sizes for research studies and early phase clinical trials, and has also contributed chapters for various other books. He has served on a number of clinical trial steering committees and scientific review panels, has been an invited peer reviewer for many research papers and an Associate Editor of several scientific journals, including Statistics in Medicine, Contemporary Clinical Trials and the Journal of Biopharmaceutical Statistics.